Zinc in PDB 5ser: Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide, PDB code: 5ser
was solved by
C.Joseph,
A.Flohr,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.50 /
2.25
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.109,
135.109,
234.956,
90,
90,
120
|
R / Rfree (%)
|
17.2 /
23.3
|
Other elements in 5ser:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
(pdb code 5ser). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide, PDB code: 5ser:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5ser
Go back to
Zinc Binding Sites List in 5ser
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:42.2
occ:1.00
|
OD2
|
A:ASP564
|
2.1
|
36.5
|
1.0
|
O
|
A:HOH941
|
2.1
|
30.9
|
1.0
|
O
|
A:HOH956
|
2.1
|
35.4
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
41.5
|
1.0
|
NE2
|
A:HIS563
|
2.1
|
34.9
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
41.8
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
32.0
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
38.1
|
1.0
|
CG
|
A:ASP674
|
3.1
|
37.4
|
1.0
|
CG
|
A:ASP564
|
3.1
|
33.8
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
37.6
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
42.2
|
1.0
|
OD2
|
A:ASP674
|
3.3
|
38.7
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
35.0
|
1.0
|
MG
|
A:MG802
|
3.8
|
34.2
|
1.0
|
O
|
A:HOH967
|
4.1
|
28.5
|
1.0
|
O
|
A:HOH936
|
4.1
|
43.2
|
1.0
|
CG
|
A:HIS563
|
4.2
|
36.7
|
1.0
|
CD2
|
A:HIS525
|
4.2
|
35.0
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
37.6
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
39.9
|
1.0
|
CG
|
A:HIS529
|
4.3
|
35.8
|
1.0
|
CB
|
A:ASP564
|
4.3
|
31.3
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
41.0
|
1.0
|
CB
|
A:ASP674
|
4.4
|
37.5
|
1.0
|
O
|
A:HOH977
|
4.5
|
60.0
|
1.0
|
O
|
A:HOH916
|
4.6
|
29.0
|
1.0
|
CG2
|
A:VAL533
|
4.8
|
28.7
|
1.0
|
CA
|
A:ASP674
|
4.9
|
37.1
|
1.0
|
O
|
A:ASP674
|
4.9
|
35.8
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5ser
Go back to
Zinc Binding Sites List in 5ser
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:40.8
occ:1.00
|
O
|
B:HOH955
|
1.9
|
27.7
|
1.0
|
OD2
|
B:ASP564
|
2.1
|
34.7
|
1.0
|
NE2
|
B:HIS563
|
2.2
|
33.2
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
28.6
|
1.0
|
OD1
|
B:ASP674
|
2.2
|
33.0
|
1.0
|
O
|
B:HOH956
|
2.6
|
41.0
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
38.5
|
1.0
|
CG
|
B:ASP674
|
3.1
|
31.2
|
1.0
|
CG
|
B:ASP564
|
3.1
|
33.4
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
37.6
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
31.2
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
37.5
|
1.0
|
OD2
|
B:ASP674
|
3.4
|
34.5
|
1.0
|
OD1
|
B:ASP564
|
3.5
|
32.7
|
1.0
|
MG
|
B:MG802
|
3.7
|
32.0
|
1.0
|
O
|
B:HOH970
|
3.9
|
27.6
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
37.9
|
1.0
|
O
|
B:HOH907
|
4.1
|
37.9
|
1.0
|
CG
|
B:HIS563
|
4.2
|
32.8
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
31.6
|
1.0
|
CG
|
B:HIS529
|
4.3
|
33.2
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
34.9
|
1.0
|
CB
|
B:ASP564
|
4.3
|
32.5
|
1.0
|
O
|
B:HOH984
|
4.4
|
60.6
|
1.0
|
NE2
|
B:HIS525
|
4.5
|
36.7
|
1.0
|
CB
|
B:ASP674
|
4.5
|
31.6
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
29.6
|
1.0
|
O
|
B:HOH927
|
4.8
|
35.3
|
1.0
|
O
|
B:ASP674
|
4.8
|
34.2
|
1.0
|
CA
|
B:ASP674
|
4.9
|
30.0
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5ser
Go back to
Zinc Binding Sites List in 5ser
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:40.2
occ:1.00
|
O
|
C:HOH929
|
1.9
|
29.6
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
36.4
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
36.8
|
1.0
|
NE2
|
C:HIS529
|
2.2
|
36.2
|
1.0
|
NE2
|
C:HIS563
|
2.3
|
33.1
|
1.0
|
O
|
C:HOH951
|
2.3
|
42.6
|
1.0
|
CG
|
C:ASP674
|
3.1
|
35.6
|
1.0
|
CD2
|
C:HIS563
|
3.1
|
32.1
|
1.0
|
CG
|
C:ASP564
|
3.1
|
32.4
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
37.1
|
1.0
|
CD2
|
C:HIS529
|
3.2
|
39.3
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
37.0
|
1.0
|
CE1
|
C:HIS563
|
3.4
|
34.0
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
33.4
|
1.0
|
MG
|
C:MG802
|
3.7
|
33.6
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
40.4
|
1.0
|
O
|
C:HOH978
|
4.2
|
33.9
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
34.6
|
1.0
|
CG
|
C:HIS563
|
4.3
|
34.5
|
1.0
|
CG
|
C:HIS529
|
4.3
|
35.7
|
1.0
|
CB
|
C:ASP564
|
4.3
|
26.6
|
1.0
|
O
|
C:HOH936
|
4.3
|
40.7
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
42.3
|
1.0
|
ND1
|
C:HIS563
|
4.4
|
32.9
|
1.0
|
CB
|
C:ASP674
|
4.5
|
33.9
|
1.0
|
O
|
C:HOH981
|
4.5
|
49.7
|
1.0
|
O
|
C:HOH928
|
4.5
|
35.3
|
1.0
|
CA
|
C:ASP674
|
4.8
|
37.4
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
33.1
|
1.0
|
O
|
C:HOH942
|
4.9
|
35.4
|
1.0
|
O
|
C:ASP674
|
5.0
|
37.8
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5ser
Go back to
Zinc Binding Sites List in 5ser
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-N- (2-Fluoroethyl)-4-N,2-Dimethyl-3-N-(2-Phenyl-[1,2,4]Triazolo[1,5- A]Pyridin-7-Yl)Pyrazole-3,4-Dicarboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:56.5
occ:1.00
|
OD2
|
D:ASP564
|
2.1
|
61.4
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
44.1
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
67.6
|
1.0
|
O
|
D:HOH911
|
2.2
|
34.9
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
50.3
|
1.0
|
O
|
D:HOH924
|
2.3
|
45.6
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
53.5
|
1.0
|
CG
|
D:ASP564
|
3.1
|
50.8
|
1.0
|
CG
|
D:ASP674
|
3.2
|
51.1
|
1.0
|
CD2
|
D:HIS529
|
3.2
|
55.3
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
52.3
|
1.0
|
CE1
|
D:HIS563
|
3.2
|
42.8
|
1.0
|
OD2
|
D:ASP674
|
3.4
|
55.2
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
52.3
|
1.0
|
O
|
D:HOH908
|
3.9
|
43.0
|
1.0
|
MG
|
D:MG802
|
4.0
|
48.7
|
1.0
|
CB
|
D:ASP564
|
4.2
|
44.7
|
1.0
|
CG
|
D:HIS563
|
4.2
|
50.9
|
1.0
|
CD2
|
D:HIS525
|
4.3
|
68.7
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
52.5
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
55.2
|
1.0
|
CG
|
D:HIS529
|
4.4
|
51.3
|
1.0
|
CB
|
D:ASP674
|
4.5
|
55.2
|
1.0
|
NE2
|
D:HIS525
|
4.6
|
61.4
|
1.0
|
O
|
D:HOH903
|
4.6
|
47.9
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
53.7
|
1.0
|
O
|
D:ASP674
|
4.9
|
62.5
|
1.0
|
CA
|
D:ASP674
|
5.0
|
55.6
|
1.0
|
O
|
D:HOH902
|
5.0
|
48.2
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:46:48 2024
|